FREMONT, Calif., Oct. 23 /PRNewswire-FirstCall/ -- WaferGen Biosystems, Inc. (OTC Bulletin Board: WGBS), a leading developer of state-of-the-art gene expression, genotyping, cell biology and stem cell research systems, today announced that Alnoor Shivji, WaferGen's president and chief executive officer, will deliver a corporate presentation at the Seventh Annual BIO Investor Forum. The conference will be held October 28-31, 2008, at the Palace Hotel in San Francisco
WaferGen's presentation will take place at 11:30 a.m. (PST) on Thursday, October 30, 2008. The presentation will include an overview of the company's SmartChip(TM) Real-Time PCR System, which is currently being developed for the gene expression and genotyping markets, and the SmartSlide(TM) Micro- Incubation System that WaferGen is actively marketing. A live webcast and 90- day archived presentation can be accessed at http://www.wafergen.com.
WaferGen Biosystems, Inc. is a leader in the development, manufacture
and sale of state-of-the-art systems for gene expression, genotyping, cell
biology and stem cell research for the life science and pharmaceutical
industries. The company is actively developing its SmartChip(TM) product
for the gene expression and genotyping markets. SmartChip is being
developed as the first whole genome, high throughput gene expression
real-time polymerase chain reaction (PCR) platform. This innovative system,
combined with next-generation chemistry and optimized assays being
developed by WaferGen, promises to deliver significant speed and cost
advantages to researchers in the gene expression and genotyping markets.
Based on collaborations established with leading research institutions,
WaferGen believes that the SmartChip Real-Time PCR System is positioned as
the platform of choice for biomarker discovery and validation. WaferGen
currently markets its SmartSlide(TM) family of products t
|SOURCE WaferGen Biosystems, Inc.|
Copyright©2008 PR Newswire.
All rights reserved